Table 1 Participants’ characteristics
Total | Patients seen in the ED and released | Patients seen in the ED and admitted | |
|---|---|---|---|
Number of unique patients (n,%) | 1144 (100%) | 763 (66.7%) | 381 (33.3%) |
Age in years (mean; sd)a | 20.4 (14.8) | 21.6 (14.9) | 17.9 (14.3) |
Sex (n,%) | |||
Male | 579 (50.6%) | 381 (33.3%) | 198 (17.3%) |
Female | 565 (49.4%) | 382 (33.4%) | 183 (16.0%) |
Sickle genotype (n,%) | |||
HbSS and HbSβ0-thalassemia | 903 (78.9%) | 596 (52.1%) | 307 (26.8%) |
HbSC and HbSβ+-thalassemia | 241 (21.1%) | 167 (14.6%) | 74 (6.5%) |
Hydroxyurea therapy at any point during the study period (n,%) | 441 (38.5%) | 285 (24.9%) | 156 (13.6%) |